Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
a First-in-Class
.
Show all posts
Showing posts with label
a First-in-Class
.
Show all posts
Monday, November 3, 2025
FDA Approves Journavx (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain
›
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced U.S. Food and Drug Administration (FDA) approval of Journavx (suzetrigin...
›
Home
View web version
